Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiyi Ji

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Prostate|May 16, 2023
<sup>18</sup> F-FDG PET/CT imaging in neuroendocrine prostate cancer: Relation to histopathology and prognosisKai Shen, Minghao Yu, Yiyi Ji, et al.
Magnetic Resonance in Medicine|October 9, 2014
On the RF heating of coronary stents at 7.0 Tesla MRILukas Winter, Eva Oberacker, Celal Özerdem, et al.
Experimental Cell Research|April 10, 2022
Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transitionLei Chen, Hailong Liu, Yiyi Ji, et al.
Radiation Oncology (London, England)|September 23, 2015
Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz)Lukas Winter, Celal Oezerdem, Werner Hoffmann, et al.
Frontiers in Oncology|March 30, 2023
High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancerLei Chen, Yiyi Ji, Ang Li, et al.
Cancer Letters|February 2, 2025
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathwayYizheng Xue, Tianyi Chen, Zehua Ma, et al.
Plos One|August 31, 2013
Enlargement of cerebral ventricles as an early indicator of encephalomyelitisStefano Lepore, Helmar Waiczies, Jan Hentschel, et al.
Cancers|May 31, 2020
Controlled Release of Therapeutics from Thermoresponsive Nanogels: A Thermal Magnetic Resonance Feasibility StudyYiyi Ji, Lukas Winter, Lucila Navarro, et al.
Frontiers in Oncology|August 29, 2022
Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiationRuopeng Su, Lei Chen, Zhou Jiang, et al.
Annals of Medicine|October 11, 2024
Prognostic value of [<sup>18</sup>F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort studyAng Li, Kai Shen, Yiyi Ji, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Prostate|May 16, 2023
<sup>18</sup> F-FDG PET/CT imaging in neuroendocrine prostate cancer: Relation to histopathology and prognosisKai Shen, Minghao Yu, Yiyi Ji, et al.
Magnetic Resonance in Medicine|October 9, 2014
On the RF heating of coronary stents at 7.0 Tesla MRILukas Winter, Eva Oberacker, Celal Özerdem, et al.
Experimental Cell Research|April 10, 2022
Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transitionLei Chen, Hailong Liu, Yiyi Ji, et al.
Radiation Oncology (London, England)|September 23, 2015
Thermal magnetic resonance: physics considerations and electromagnetic field simulations up to 23.5 Tesla (1GHz)Lukas Winter, Celal Oezerdem, Werner Hoffmann, et al.
Frontiers in Oncology|March 30, 2023
High-throughput drug screening identifies fluoxetine as a potential therapeutic agent for neuroendocrine prostate cancerLei Chen, Yiyi Ji, Ang Li, et al.
Cancer Letters|February 2, 2025
Osalmid sensitizes clear cell renal cell carcinoma to navitoclax through a STAT3/BCL-XL pathwayYizheng Xue, Tianyi Chen, Zehua Ma, et al.
Plos One|August 31, 2013
Enlargement of cerebral ventricles as an early indicator of encephalomyelitisStefano Lepore, Helmar Waiczies, Jan Hentschel, et al.
Cancers|May 31, 2020
Controlled Release of Therapeutics from Thermoresponsive Nanogels: A Thermal Magnetic Resonance Feasibility StudyYiyi Ji, Lukas Winter, Lucila Navarro, et al.
Frontiers in Oncology|August 29, 2022
Comprehensive analysis of androgen receptor status in prostate cancer with neuroendocrine differentiationRuopeng Su, Lei Chen, Zhou Jiang, et al.
Annals of Medicine|October 11, 2024
Prognostic value of [<sup>18</sup>F]FDG PET/CT in metastatic hormone-sensitive prostate cancer at initial diagnosis: a retrospective cohort studyAng Li, Kai Shen, Yiyi Ji, et al.
Pageof 4